Comparison of clinical outcome of induction immunosuppressive therapy with thymoglobulin and standard therapy in kidney transplantation; a randomized double-blind clinical trial

• Main Authors: Heshmatollah Shahbazian (Author), Ali Ghorbani (Author), Fatemeh Hayati (Author), Seyed Seifollah Beladi Mousavi (Author), Leila Sabetnia (Author), Shahla Ahmadi Halili (Author), Shokouh Shayanpour (Author), Isa Rezaee (Author)
• Formato: Livro
• Publicado em: Society of Diabetic Nephropathy Prevention, 2020-01-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

Introduction: Thymoglobulin is a lymphocyte-depleting polyclonal antibody, administered for induction therapy at the time of kidney transplantation to reduce the risk of acute allograft rejection. The appropriate dosage and duration of therapy is controversial. The higher dosages are associated with...